|
|
NeuroVentures
is a specialty
venture capital firm dedicated to investing in companies focused on the
discovery, development and marketing of new drugs, medical devices and
other therapeutics and technologies to treat Central Nervous System
disorders. Founded in 2000,
NeuroVentures is led by a team of experienced venture capital and life
science professionals and advised by an internationally recognized network
of medical and scientific thought leaders. NeuroVentures serves as the
General Partner to the NeuroVentures Fund, LP, a Delaware
limited partnership with committed capital in excess of $15 million.
|
